{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:23Z","timestamp":1789685003361,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.06.083","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T04:00:30Z","timestamp":1373256030000},"page":"4079-4083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization"],"prefix":"10.1016","volume":"31","author":[{"given":"Nitipong","family":"Permpalung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supakanya","family":"Wongrakpanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sira","family":"Korpaisarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pansakorn","family":"Tanratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaruboot","family":"Angsanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0005","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0010","first-page":"1","volume":"vol. 824","author":"WHO Expert Committee on Rabies","year":"1992"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-387040-7.00013-5","article-title":"Postexposure prophylaxis for rabies in resource-limited\/poor countries","volume":"79","author":"Shantavasinkul","year":"2011","journal-title":"Adv Virus Res"},{"issue":"44","key":"10.1016\/j.vaccine.2013.06.083_bib0020","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper-recommendations","volume":"28","author":"WHO","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0025","volume":"vol. 709","year":"1984"},{"issue":"51","key":"10.1016\/j.vaccine.2013.06.083_bib0030","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/clinids\/20.3.646","article-title":"Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen","volume":"20","author":"Khawplod","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.06.083_bib0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0264-410X(94)90308-5","article-title":"A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis","volume":"12","author":"Suntharasamai","year":"1994","journal-title":"Vaccine"},{"issue":"8694","key":"10.1016\/j.vaccine.2013.06.083_bib0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0140-6736(90)90488-Q","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0950268800066619","article-title":"Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis","volume":"99","author":"Suntharasamai","year":"1987","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0055","first-page":"491","article-title":"An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment","volume":"63","author":"Ubol","year":"1986","journal-title":"Clin Exp Immunol"},{"issue":"8345","key":"10.1016\/j.vaccine.2013.06.083_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(83)90288-X","article-title":"An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis","volume":"2","author":"Warrell","year":"1983","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.vaccine.2013.06.083_bib0065","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.vaccine.2006.01.051","article-title":"Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection","volume":"24","author":"Khawplod","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0070","first-page":"309","article-title":"Rabies vaccines. WHO position paper","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.083_bib0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/649211","article-title":"Postexposure rabies prophylaxis completed in 1 week: preliminary study","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2013.06.083_bib0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum Vaccines Immunother"},{"issue":"18","key":"10.1016\/j.vaccine.2013.06.083_bib0085","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2013.06.083_bib0090","first-page":"1","article-title":"Human rabies prevention \u2013 United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2013.06.083_bib0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2310\/7060.2002.30088","article-title":"The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic","volume":"9","author":"Lau","year":"2002","journal-title":"J Travel Med"},{"issue":"31","key":"10.1016\/j.vaccine.2013.06.083_bib0100","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.vaccine.2008.04.081","article-title":"Intradermal pre-exposure rabies vaccine elicits long lasting immunity","volume":"26","author":"Brown","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2013.06.083_bib0105","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jama.1982.03320330034022","article-title":"Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses","volume":"247","author":"Bernard","year":"1982","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2013.06.083_bib0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.1987.03390080049028","article-title":"Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination","volume":"257","author":"Bernard","year":"1987","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.vaccine.2013.06.083_bib0115","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.vaccine.2011.12.028","article-title":"One clinic visit for pre-exposure rabies vaccination (a preliminary one year study)","volume":"30","author":"Khawplod","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedulev \u2013 a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0125","first-page":"393","article-title":"One or three intradermal injections within one week for rabies pre-exposure immunization","volume":"131","author":"Khawplod","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies preexposure vaccination schedules","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"issue":"9","key":"10.1016\/j.vaccine.2013.06.083_bib0135","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0140","first-page":"375","article-title":"Elimination of human rabies in a canine endemic province in Thailand: five-year programme","volume":"81","author":"Kamoltham","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.083_bib0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0035-9203(99)90309-7","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Vietnam: results of a comparative randomized trial","volume":"93","author":"Lang","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.083_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/tropej\/fmm100","article-title":"Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam","volume":"55","author":"Lang","year":"2009","journal-title":"J Trop Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2013.06.083_bib0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12\u201318-month-old Thai children, concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"38","key":"10.1016\/j.vaccine.2013.06.083_bib0160","first-page":"494","article-title":"Human rabies \u2013 Kenya","volume":"32","year":"1983","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0165","first-page":"1","volume":"vol. 931","author":"WHO Expert Consultation on Rabies","year":"2005"},{"issue":"11","key":"10.1016\/j.vaccine.2013.06.083_bib0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00006454-199811000-00007","article-title":"Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine","volume":"17","author":"Sabchareon","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0175","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1086\/513760","article-title":"Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations","volume":"25","author":"Kositprapa","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0180","doi-asserted-by":"crossref","first-page":"403201","DOI":"10.4061\/2011\/403201","article-title":"Immunogenicity of simulated pcecv postexposure booster doses 1, 3, and 5 years after 2-dose and 3-dose primary rabies vaccination in school children","volume":"2011","author":"Kamoltham","year":"2011","journal-title":"Adv Prev Med"},{"issue":"27-28","key":"10.1016\/j.vaccine.2013.06.083_bib0185","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.vaccine.2008.04.033","article-title":"Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults","volume":"26","author":"Roukens","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.083_bib0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0264-410X(89)90159-X","article-title":"Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations","volume":"7","author":"Fishbein","year":"1989","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0200","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2105\/AJPH.74.5.503","article-title":"Intradermal immunization with human diploid cell rabies vaccine: serological and clinical responses of immunized persons to intradermal booster vaccination","volume":"74","author":"Burridge","year":"1984","journal-title":"Am J Public Health"},{"issue":"16","key":"10.1016\/j.vaccine.2013.06.083_bib0205","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0264-410X(96)00090-4","article-title":"Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with semple or suckling mouse brain vaccine","volume":"14","author":"Khawplod","year":"1996","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.06.083_bib0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijid.2004.02.008","article-title":"Rabies deaths in Pakistan: results of ineffective post-exposure treatment","volume":"8","author":"Parviz","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2013.06.083_bib0215","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0264-410X(00)00342-X","article-title":"Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons","volume":"19","author":"Briggs","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.083_bib0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7060.2002.23189","article-title":"Four-site intradermal postexposure boosters in previously rabies vaccinated subjects","volume":"9","author":"Khawplod","year":"2002","journal-title":"J Travel Med"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.083_bib0225","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1086\/514737","article-title":"Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine","volume":"28","author":"Tantawichien","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2013.06.083_bib0230","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1086\/338155","article-title":"Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2013.06.083_bib0235","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/656585","article-title":"A 4-site, single-visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients","volume":"51","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"RR-2","key":"10.1016\/j.vaccine.2013.06.083_bib0240","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.083_bib0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/cis384","article-title":"Rabies post-exposure prophylaxis in routine practice in view of the new CDC and WHO recommendations","volume":"55","author":"Uwanyiligira","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0250","series-title":"Clinical trials: immunogenicity study of a reduced (4-dose) vaccine schedule and rabies immunoglobulins [database on the internet]","year":"2012"},{"key":"10.1016\/j.vaccine.2013.06.083_bib0255","series-title":"Clinical trials: immunogenicity and safety of verorab\u00ae in a \u201cone-week\u201d intradermal post-exposure prophylaxis regimen [database on the internet]","year":"2012"},{"issue":"50","key":"10.1016\/j.vaccine.2013.06.083_bib0260","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1016\/j.vaccine.2012.09.027","article-title":"Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults","volume":"30","author":"Gogtay","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T19:30:55Z","timestamp":1539545455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":52,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0264410X13008931"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}